{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:58:38Z","timestamp":1764997118925,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T00:00:00Z","timestamp":1485561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00277-017-2930-0","type":"journal-article","created":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T00:45:08Z","timestamp":1485564308000},"page":"691-693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-5895","authenticated-orcid":false,"given":"Laura","family":"Talamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Douvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Gail","family":"Macik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ornan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,28]]},"reference":[{"key":"2930_CR1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1200\/JCO.1997.15.6.2222","volume":"15","author":"J Nachman","year":"1997","unstructured":"Nachman J, Sather HN, Gaynon PS, Lukens JN, Wolff L, Trigg ME (1997) Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the children\u2019s cancer group. J Clin Oncol 15:2222\u20132230","journal-title":"J Clin Oncol"},{"key":"2930_CR2","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1080\/10428190802517732","volume":"49","author":"JE Chang","year":"2008","unstructured":"Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J, Kim K, Kim J, Esterberg E, Juckett MB (2008) Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma 49:2298\u20132307","journal-title":"Leuk Lymphoma"},{"key":"2930_CR3","unstructured":"Stock W, Luger SM, Advani AS, Geyer S, Harvey RC, Mullighan CG, Willman CL, Malnassy G, Parker E, Laumann KM, Sanford B, Marcucci G, Paietta EM, Liedtke M, Claxton DF, Foster MC, Appelbaum FR, Erba H, Litzow MR, Tallman MS, Stone RM, Larson RA (2014) Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of U.S. Intergroup Trial C10403. In: Editor (ed)^(eds) Book Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of U.S. Intergroup Trial C10403. Blood, City, pp. 796"},{"key":"2930_CR4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1097-0142(196612)19:12<1813::AID-CNCR2820191208>3.0.CO;2-E","volume":"19","author":"WC Dolowy","year":"1966","unstructured":"Dolowy WC, Henson D, Cornet J, Sellin H (1966) Toxic and antineoplastic effects of L-asparaginase: study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer 19:1813\u20131819","journal-title":"Cancer"},{"key":"2930_CR5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1967.03130220070012","volume":"202","author":"JM Hill","year":"1967","unstructured":"Hill JM, Roberts J, Loeb E, Khan A, MacLellan A, Hill RW (1967) L-asparaginase therapy for leukemia and other malignant neoplasms: remission in human leukemia. JAMA 202:882\u2013888","journal-title":"JAMA"},{"key":"2930_CR6","first-page":"5601","volume":"43","author":"SE Sallan","year":"1983","unstructured":"Sallan SE, Hitchcock-Bryan S, Gelber R, Cassady JR, Frei E 3rd, Nathan DG (1983) Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 43:5601\u20135607","journal-title":"Cancer Res"},{"key":"2930_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a pediatric oncology group study. Leukemia 13:335\u2013342","journal-title":"Leukemia"},{"key":"2930_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2007-976171","volume":"33","author":"A Zakarija","year":"2007","unstructured":"Zakarija A, Kwaan HC (2007) Adverse effects on hemostatic function of drugs used in hematologic malignancies. Semin Thromb Hemost 33:355\u2013364","journal-title":"Semin Thromb Hemost"},{"key":"2930_CR9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","volume":"152","author":"RF Grace","year":"2011","unstructured":"Grace RF, Dahlberg SE, Neuberg D, Sallan SE, Connors JM, Neufeld EJ, Deangelo DJ, Silverman LB (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 152:452\u2013459","journal-title":"Br J Haematol"},{"key":"2930_CR10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1253\/circj.CJ-15-0195","volume":"79","author":"M Nakamura","year":"2015","unstructured":"Nakamura M, Nishikawa M, Komuro I, Kitajima I, Uetsuka Y, Yamagami T, Minamiguchi H, Yoshimatsu R, Tanabe K, Matsuoka N, Kanmuri K, Ogawa H (2015) Apixaban for the treatment of Japanese subjects with acute venous thromboembolism (AMPLIFY-J study). Circ J 79:1230\u20131236","journal-title":"Circ J"},{"key":"2930_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","volume":"168","author":"S Goto","year":"2014","unstructured":"Goto S, Zhu J, Liu L, Oh BH, Wojdyla DM, Aylward P, Bahit MC, Gersh BJ, Hanna M, Horowitz J, Lopes RD, Wallentin L, Xavier D, Alexander JH (2014) Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J 168:303\u2013309","journal-title":"Am Heart J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2930-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-2930-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2930-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:14:05Z","timestamp":1498367645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-2930-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,28]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-2930-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2017,1,28]]}}}